Recommended Journals

Fetal Macrosomia

Share this page

The term macrosomia is used to describe a newborn with an excessive birth weight. It can be known only after the child birth and the condition is confirmed only retrospectively, ie, after delivery of the neonate. Fetal macrosomia has been defined in several different ways, including birth weight of 4000-4500 g (8 lb 13 oz to 9 lb 15 oz) or greater than 90% for gestational age after correcting for neonatal sex and ethnicity.
Macrosomia may be associated with birth trauma for the neonate and birth canal lacerations, eg, perineal, vaginal, and cervical, or cesarean delivery for the mother. However, macrosomia in the neonate of a diabetic mother may indicate poor glucose control. Possible signs and symptoms include: Large fundal height (A fundal height that measures larger than expected could be a sign of fetal macrosomia.) Excessive amniotic fluid (The amount of amniotic fluid reflects your baby's urine output, and a larger baby produces more urine.)
Variation in the percentage of macrosomia in different ethnic groups has been observed independent of diabetes. In general, Hispanic women have a larger proportion of macrosomic newborns compared with white, African American, or Asian women. Macrosomic neonates are at risk for shoulder dystocia and birth trauma. This risk is directly related to neonatal birth weight and begins to increase substantially when birth weight exceeds 4500 g and particularly when it exceeds 5000 g. Male infants are more likely to be macrosomic than female infants. Macrosomia occurs with higher frequency in newborns of Hispanic origin.

Expert PPTs

Salvatore Andrea Mastrolia
Obstetrics and Gynecology
PPT Version | PDF Version
Nilanchali Singh
Obstetrics and Gynaecology
PPT Version | PDF Version

Speaker PPTs

Moorkath Nandakumaran
Hyperglycemia alters maternal-fetal transport kinetics of manganese, chromium and vanadium in diabetic model human placental lobule in vitro : Implications for diabetes mellitu
PPT Version | PDF Version
Yosef Yarden
Classically, the 3âuntranslated region (3âUTR) is that region in eukaryotic protein-coding genes from the translation termination codon to the polyA signal. It is transcribed as an integral part of the mRNA encoded by the gene. However, there exists another kind of RNA, which consists of the 3âUTR alone, without all other elements in mRNA such as 5âUTR and coding region. The importance of independent 3âUTR RNA (referred as I3âUTR) was prompted by results of artificially introducing such RNA species into malignant mammalian cells. Since 1991, we found that the middle part of the 3âUTR of the human nuclear factor for interleukin-6 (NF-IL6) or C/EBP gene exerted tumor suppression effect in vivo. Our subsequent studies showed that transfection of C/EBP 3âUTR led to down-regulation of several genes favorable for malignancy and to up-regulation of some genes favorable for phenotypic reversion. Also, it was shown that the sequences near the termini of the C/EBP 3âUTR were important for its tumor suppression activity. Then, the C/EBP 3âUTR was found to directly inhibit the phosphorylation activity of protein kinase CPKC in SMMC-7721, a hepatocarcinoma cell line. Recently, an AU-rich region in the C/EBP 3âUTR was found also to be responsible for its tumor suppression. Recently we have also found evidence that the independent C/EBP 3âUTR RNA is actually exists in human tissues, such as fetal liver and heart, pregnant uterus, senescent fibroblasts etc. Through 1990âs to 2000âs, world scientists found several 3âUTR RNAs that functioned as artificial independent RNAs in cancer cells and resulted in tumor suppression. Interestingly, majority of genes for these RNAs have promoter-like structures in their 3âUTR regions, although the existence of their transcribed products as independent 3âUTR RNAs is still to be confirmed. Our studies indicate that the independent 3âUTR RNA is a novel non-coding RNA species whose function should be the regulation not of the expression of their original mRNA, but of some essential life activities of the cell as a whole.
PPT Version | PDF Version
Simona Claudia Cambrea
PDF Version
Guinchard Emmanuelle
PDF Version
Dong Zheng
The protective effect of Astaxanthin on fetal alcohol spectrum disorder in mice
PPT Version | PDF Version

Recommended Journals

Relevant Topics

Fetal Macrosomia

Expert PPTs

Speaker PPTs

High Impact List of Articles

Conference Proceedings

International Conferences 2019-20

Conferences By Continents

USA & Americas

Asia-Pacific & Middle East

Europe

Medical & Clinical Conferences

Conferences by Subject

Contact Us